CSL USA/Sacco System expands U.S. CDMO capabilities for microbiome innovation

Seven finished-product concepts showcase science-backed microorganisms and end-to-end manufacturing capabilities

This October, CSL USA/Sacco System is heading to SupplySide Global 2026 in Las Vegas, bringing expanded capabilities and new possibilities for microbiome innovation.

Discover our enhanced end-to-end U.S. CDMO capabilities, designed to support your product from early development through commercial manufacturing, including strain development, fermentation, freeze-drying, formulation, encapsulation and finished-product packaging.

See innovation come to life

At the show, we’ll be showcasing 7 finished-product concepts, demonstrating how science-backed microorganisms can be translated into differentiated, market-ready solutions across some of today’s most relevant health categories:

Metabolic health • Healthy ageing • Weight management • Digestive health • Women’s health • Immune health • Hydration

Explore what’s possible:

Probiotics & postbiotics

Science-backed strains supported by Sacco System’s deep microbiome expertise.

Finished-product innovation

Explore our 7 ready-to-discuss concepts featuring scientifically supported strains and targeted formulations designed to inspire your next product innovation.

Next-generation probiotics

Growing capabilities to support challenging microorganisms from development and scale-up through finished dosage formats.

End-to-end CDMO services

An integrated approach connecting research, process development and industrial manufacturing.

From promising microorganisms to finished products, Sacco System and CSL USA bring science, development and manufacturing together to help turn microbiome innovation into commercial reality.

 Visit us at SupplySide Global 2026 booth 7071 and discover what we can build together.

Relevant companies

You may also like